| 1. |
|
|
| 2. |
|
|
| 3. |
|
|
| 4. |
- Ooi, BNS, et al.
(författare)
-
The genetic interplay between body mass index, breast size and breast cancer risk: a Mendelian randomization analysis
- 2019
-
Ingår i: International journal of epidemiology. - : Oxford University Press (OUP). - 1464-3685 .- 0300-5771. ; 48:3, s. 781-794
-
Tidskriftsartikel (refereegranskat)abstract
- BackgroundEvidence linking breast size to breast cancer risk has been inconsistent, and its interpretation is often hampered by confounding factors such as body mass index (BMI). Here, we used linkage disequilibrium score regression and two-sample Mendelian randomization (MR) to examine the genetic associations between BMI, breast size and breast cancer risk.MethodsSummary-level genotype data from 23andMe, Inc (breast size, n = 33 790), the Breast Cancer Association Consortium (breast cancer risk, n = 228 951) and the Genetic Investigation of ANthropometric Traits (BMI, n = 183 507) were used for our analyses. In assessing causal relationships, four complementary MR techniques [inverse variance weighted (IVW), weighted median, weighted mode and MR-Egger regression] were used to test the robustness of the results.ResultsThe genetic correlation (rg) estimated between BMI and breast size was high (rg = 0.50, P = 3.89x10−43). All MR methods provided consistent evidence that higher genetically predicted BMI was associated with larger breast size [odds ratio (ORIVW): 2.06 (1.80–2.35), P = 1.38x10−26] and lower overall breast cancer risk [ORIVW: 0.81 (0.74–0.89), P = 9.44x10−6]. No evidence of a relationship between genetically predicted breast size and breast cancer risk was found except when using the weighted median and weighted mode methods, and only with oestrogen receptor (ER)-negative risk. There was no evidence of reverse causality in any of the analyses conducted (P > 0.050).ConclusionOur findings indicate a potential positive causal association between BMI and breast size and a potential negative causal association between BMI and breast cancer risk. We found no clear evidence for a direct relationship between breast size and breast cancer risk.
|
|
| 5. |
- Tsuboi, Masahito, et al.
(författare)
-
Brain size evolution in pipefishes and seahorses : the role of feeding ecology, life history and sexual selection
- 2017
-
Ingår i: Journal of Evolutionary Biology. - : Wiley. - 1010-061X .- 1420-9101. ; 30:1, s. 150-160
-
Tidskriftsartikel (refereegranskat)abstract
- Brain size varies greatly at all taxonomic levels. Feeding ecology, life history and sexual selection have been proposed as key components in generating contemporary diversity in brain size across vertebrates. Analyses of brain size evolution have, however, been limited to lineages where males predominantly compete for mating and females choose mates. Here, we present the first original data set of brain sizes in pipefishes and seahorses (Syngnathidae) a group in which intense female mating competition occurs in many species. After controlling for the effect of shared ancestry and overall body size, brain size was positively correlated with relative snout length. Moreover, we found that females, on average, had 4.3% heavier brains than males and that polyandrous species demonstrated more pronounced (11.7%) female-biased brain size dimorphism. Our results suggest that adaptations for feeding on mobile prey items and sexual selection in females are important factors in brain size evolution of pipefishes and seahorses. Most importantly, our study supports the idea that sexual selection plays a major role in brain size evolution, regardless of on which sex sexual selection acts stronger.
|
|
| 6. |
- Chin, C., et al.
(författare)
-
Simulation of a Large-Eddy-Break-up Device (LEBU) in a Moderate Reynolds Number Turbulent Boundary Layer
- 2016
-
Ingår i: Flow Turbulence and Combustion. - : Springer. - 1386-6184 .- 1573-1987. ; , s. 1-16
-
Tidskriftsartikel (refereegranskat)abstract
- A well-resolved large eddy simulation (LES) of a large-eddy break-up (LEBU) device in a spatially evolving turbulent boundary layer is performed with, Reynolds number, based on free-stream velocity and momentum-loss thickness, of Reθ ≈ 4300. The implementation of the LEBU is via an immersed boundary method. The LEBU is positioned at a wall-normal distance of 0.8 δ (δ denoting the local boundary layer thickness at the location of the LEBU) from the wall. The LEBU acts to delay the growth of the turbulent boundary layer and produces global skin friction reduction beyond 180δ downstream of the LEBU, with a peak local skin friction reduction of approximately 12 %. However, no net drag reduction is found when accounting for the device drag of the LEBU in accordance with the towing tank experiments by Sahlin et al. (Phys. Fluids 31, 2814, 1988). Further investigation is performed on the interactions of high and low momentum bulges with the LEBU and the corresponding output is analysed, showing a ‘break-up’ of these large momentum bulges downstream of the LEBU. In addition, results from the spanwise energy spectra show consistent reduction in energy at spanwise length scales for (Formula presented.) independent of streamwise and wall-normal location when compared to the corresponding turbulent boundary layer without LEBU.
|
|
| 7. |
|
|
| 8. |
|
|
| 9. |
|
|
| 10. |
- Ooi, E. M., et al.
(författare)
-
Triglyceride-rich lipoprotein metabolism in women: roles of apoC-II and apoC-III
- 2016
-
Ingår i: European Journal of Clinical Investigation. - : Wiley. - 0014-2972 .- 1365-2362. ; 46:8, s. 730-736
-
Tidskriftsartikel (refereegranskat)abstract
- Background: Experimental data suggest that apolipoprotein (apo) C-II and C-III regulate triglyceride-rich lipoprotein (TRL) metabolism, but there are limited studies in humans. We investigated the metabolic associations of TRLs with apoC-II and apoC-III concentrations and kinetics in women. Material and methods: The kinetics of plasma apoC-II, apoC-III and very low-density lipoprotein (VLDL) apoB-100 and triglycerides were measured in the postabsorptive state using stable isotopic techniques and compartmental modelling in 60 women with wide-ranging body mass index (19·5–32·9kg/m2). Results: Plasma apoC-II and apoC-III concentrations were positively associated with the concentrations of plasma triglycerides, VLDL1- and VLDL2-apoB-100 and triglyceride (all P<0·05). ApoC-II production rate (PR) was positively associated with VLDL1-apoB-100 concentration, VLDL1 triglyceride concentration and VLDL1 triglyceride PR, while apoC-II fractional catabolic rate (FCR) was positively associated with VLDL1 triglyceride FCR (all P<0·05). No significant associations were observed between apoC-II and VLDL2 apoB-100 or triglyceride kinetics. ApoC-III PR, but not FCR, was positively associated with VLDL1 triglyceride, and VLDL2-apoB-100 and triglyceride concentrations (all P<0·05). No significant associations were observed between apoC-III and VLDL-apoB-100 and triglyceride kinetics. In multivariable analysis, including homoeostasis model assessment score, menopausal status and obesity, apoC-II concentration was significantly associated with plasma triglyceride, VLDL1-apoB-100 and VLDL1 triglyceride concentrations and PR. Using the same multivariable analysis, apoC-III was significantly associated with plasma triglyceride and VLDL1- and VLDL2-apoB-100 and triglyceride concentrations and FCR. Conclusions: In women, plasma apoC-II and apoC-III concentrations are regulated by their respective PR and are significant, independent determinants of the kinetics and plasma concentrations of TRLs. © 2016 Stichting European Society for Clinical Investigation Journal Foundation
|
|
